GEIS XVIII International Symposium

Format: online.

Dates: October 16th and 17th, 2020

Thursday, October 15th:

16:00-17:00 Executive Meeting (Closed meeting)

17:30-19:30 GEIS General Assembly (members only)

Friday, October, 16th:

15:20-15:30 Welcome & Introduction
Cleofé Romagosa, Claudia Valverde

15:30-16:30 SESSION 1: FOCUSING ON PATHOLOGY AND MOLECULAR BIOLOGY
Rosa Álvarez, Miquel Tarón

15:30-15:45 Technological potentials and challenges of liquid biopsy in sarcoma
Leonardo A. Meza Zepeda, Oslo University Hospital, Oslo, Norway

15:45-16:00 What’s new in WHO 2020?
Khin Thway, The Royal Marsden Hospital, London, United Kingdom

16:00-16:15 Any news in Nerve Seath Tumors?
Cleofé Romagosa, Vall d’Hebron Institute of Oncology Barcelona

16:15-16:30 Discussion

16:30-16:35 Break

16:35-17:50 SESSION 2: CHALLENGING ISSUES
Raquel Correa, Nadia Hindi

16:35-16:50 Chordoma and chondrosarcoma What has Radiotherapy to offer and at what price?
Natalia Ares, Centro de Protonterapia Quirónsalud Madrid

16:50-17:05 TARPSWG achievings and future projects
Marco Fiore, Istituto Nazionale dei Tumori, Milan, Italy

17:05-17:20 When is isolated limb perfussion worth the trouble?
Alessandro Gronchi, Istituto Nazionale dei Tumori, Milan, Italy

17:20-17:35 How to deal with non ETS round cell sarcomas
William Tap, Memorial Sloan Kettering Cancer Center, New York (NY), USA

17:35-17:50 Discussion

17:50-17:55 Break

17:55-18:40 SESSION 3; SARCOMA SUBTYPE HIGHLIGHTED NTRK SARCOMA
Javier Martín Broto, Silvia Bagué

17:55-18:10 Pathologic insights Are we able to recognise translocated sarcomas?
Enrique De Álava, Virgen del Rocío Hospital, Seville

18:10-18:25 Treatment opportunities
Shreyas Patel, MD Anderson, Houston (TX), USA

18:25-18:40 Discussion

18:40-18:45 Break

18:45-20:00 SESSION 4: LET’S IMPROVE: ADVANCES IN IMMUNOTHERAPY
Soledad Gallego, Fina Cruz

18:45-19:00 Immune phenotypes in sarcoma Is it possible to strengthen immunogenicity
José Antonio López Martín, 12 Octubre Hospital, Madrid

19:00-19:15 TILs CARs and Modified TCR
Alena Gros, Vall d’Hebron University Hospital, Barcelona

19:15-19:30 Passive immunotherapeutics (monoclonal antibodies)
Robert Maki, Penn Medicine, Philadelphia (PA), USA

19:30-19:45 What’s the additional value of PET CT in the Response assesment to Immunotherapy
Mª José García, Clínica Universitaria de Navarra, Pamplona 19:45-20:00 Discussion

20:00-20:05 Farewell
Claudia Valverde

Saturday, October, 17th:

09:00-10:30 Patients’ Satellite Symposium
César Serrano, Javier Lavernia, Javier Martínez Trufero, Ana Sebio

Language:

Lectures will be delivered in English or Spanish. Simultaneous translation will be available on October, 16th.

Registrations:

Registration fees: